SUBSCRIBERS

GIC affiliate, ADIA unit buy minority stake in US$9b pharma company

Published Thu, Apr 27, 2017 · 09:50 PM

Singapore

AN affiliate of Singapore's sovereign wealth fund GIC and a subsidiary of the Abu Dhabi Investment Authority (ADIA) have bought a minority stake in Pharmaceutical Product Development (PPD), valuing the pharmaceutical company at US$9.05 billion.

The stake in the United States-based contract research organisation (CRO) was bought from the affiliates of Hellman & Friedman and the affiliates of The Carlyle Group.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

International

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here